Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo
- PMID:29111677
- PMCID: PMC5862780
- DOI: 10.1021/acschemneuro.7b00309
Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo
Abstract
The 5-HT2A receptor (5-HT2AR) plays an important role in various neuropsychiatric disorders, including substance use disorder and schizophrenia. Homodimerization of this receptor has been suggested, but tools that allow direct assessment of the relevance of the 5-HT2AR:5-HT2AR homodimer in these disorders are necessary. We chemically modified the selective 5-HT2AR antagonist M100907 to synthesize a series of homobivalent ligands connected by ethylene glycol linkers of varying lengths that may be useful tools for probing 5-HT2AR:5-HT2AR homodimer function. We tested these molecules for 5-HT2AR antagonist activity in a cell line stably expressing the functional 5-HT2AR and quantified a downstream signaling target, activation (phosphorylation) of extracellular regulated kinases 1/2 (ERK1/2), in comparison to in vivo efficacy of altering spontaneous or cocaine-evoked locomotor activity in rats. All of the synthetic compounds inhibited 5-HT-mediated phosphorylation of ERK1/2 in the cellular signaling assay; the potency of the bivalent ligands varied as a function of linker length, with the intermediate linker lengths being the most potent. The Ki values for the binding of bivalent ligands to 5-HT2AR were only slightly lower than the values for the parent (+)-M100907 compound, but significant selectivity for 5-HT2AR over 5-HT2BR or 5-HT2CR binding was retained. In addition, the 11-atom-linked bivalent 5-HT2AR antagonist (2 mg/kg, intraperitoneally) demonstrated efficacy on par with that of (+)-M100907 in inhibiting cocaine-evoked hyperactivity. As we develop further strategies for ligand-evoked receptor assembly and analyses of diverse signaling and functional roles, these novel homobivalent 5-HT2AR antagonist ligands will serve as useful in vitro and in vivo probes of 5-HT2AR structure and function.
Keywords: Bivalent ligand; Serotonin; Serotonin 5-HT2A receptor.
Conflict of interest statement
The authors declare no competing financial interest.
Figures



Similar articles
- Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.Gilbertson SR, Chen YC, Soto CA, Yang Y, Rice KC, Cunningham KA, Anastasio NC.Gilbertson SR, et al.Bioorg Med Chem Lett. 2018 May 1;28(8):1381-1385. doi: 10.1016/j.bmcl.2018.02.058. Epub 2018 Mar 16.Bioorg Med Chem Lett. 2018.PMID:29555153Free PMC article.
- The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH.Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL.Jensen AA, et al.Biochem Pharmacol. 2020 Jul;177:113979. doi: 10.1016/j.bcp.2020.113979. Epub 2020 Apr 13.Biochem Pharmacol. 2020.PMID:32298690
- Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT2A and 5-HT2B receptors in chondrocytes.Hori A, Nishida T, Takashiba S, Kubota S, Takigawa M.Hori A, et al.PLoS One. 2017 Nov 16;12(11):e0188014. doi: 10.1371/journal.pone.0188014. eCollection 2017.PLoS One. 2017.PMID:29145495Free PMC article.
- "Selective" serotonin 5-HT2A receptor antagonists.Casey AB, Cui M, Booth RG, Canal CE.Casey AB, et al.Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.Biochem Pharmacol. 2022.PMID:35381208Free PMC article.Review.
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches.Kantrowitz JT.Kantrowitz JT.CNS Drugs. 2020 Sep;34(9):947-959. doi: 10.1007/s40263-020-00752-2.CNS Drugs. 2020.PMID:32783116Review.
Cited by
- Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.Gilbertson SR, Chen YC, Soto CA, Yang Y, Rice KC, Cunningham KA, Anastasio NC.Gilbertson SR, et al.Bioorg Med Chem Lett. 2018 May 1;28(8):1381-1385. doi: 10.1016/j.bmcl.2018.02.058. Epub 2018 Mar 16.Bioorg Med Chem Lett. 2018.PMID:29555153Free PMC article.
- Interclass GPCR heteromerization affects localization and trafficking.Toneatti R, Shin JM, Shah UH, Mayer CR, Saunders JM, Fribourg M, Arsenovic PT, Janssen WG, Sealfon SC, López-Giménez JF, Benson DL, Conway DE, González-Maeso J.Toneatti R, et al.Sci Signal. 2020 Oct 20;13(654):eaaw3122. doi: 10.1126/scisignal.aaw3122.Sci Signal. 2020.PMID:33082287Free PMC article.
- Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology.Sachdev S, Cabalteja CC, Cheloha RW.Sachdev S, et al.Methods Cell Biol. 2021;166:205-222. doi: 10.1016/bs.mcb.2021.06.004. Epub 2021 Jul 12.Methods Cell Biol. 2021.PMID:34752333Free PMC article.
- Design of bivalent ligands targeting putative GPCR dimers.Huang B, St Onge CM, Ma H, Zhang Y.Huang B, et al.Drug Discov Today. 2021 Jan;26(1):189-199. doi: 10.1016/j.drudis.2020.10.006. Epub 2020 Oct 16.Drug Discov Today. 2021.PMID:33075471Free PMC article.Review.
- The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review.Bononi G, Lonzi C, Tuccinardi T, Minutolo F, Granchi C.Bononi G, et al.Molecules. 2024 Apr 23;29(9):1930. doi: 10.3390/molecules29091930.Molecules. 2024.PMID:38731421Free PMC article.Review.
References
- Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533–554. - PubMed
- Roth BL, Hanizavareh SM, Blum AE. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl) 2004;174:17–24. - PubMed
- Bubar MJ, Cunningham KA. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res. 2008;172:319–346. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous